Skip to main content
Home

Top menu infoNTD

  • About InfoNTD
  • News & Events
  • e-learning.infoNTD.org
Home

Main navigation InfoNTD

  • NTDs [14]
    • Buruli ulcer
    • Chagas disease
    • Dracunculiasis
    • Human African trypanosomiasis
    • Leishmaniasis
    • Leprosy
    • Lymphatic filariasis
    • Mycetoma
    • Onchocerciasis
    • Schistosomiasis
    • Snakebite envenoming
    • Soil-transmitted helminthiasis
    • Trachoma
    • Yaws
  • Cross-cutting issues [13]
    • Data management & analysis [3]
      • Data collection and reporting
      • Mapping
      • Indicators
    • Integrated wound management
    • Capacity strengthening
    • Management of disease complications [2]
      • Medical management
      • Surgical management
    • Prevention of disability [3]
      • Eye care
      • Self-care
      • Disability measurement
    • Physical rehabilitation [3]
      • Physical therapy
      • Orthopaedic footwear
      • Protheses, walking devices and wheelchairs
    • Stigma and mental wellbeing [1]
      • Mental wellbeing project mapping
    • Inclusion [2]
      • Community-based rehabilitation
      • Gender
    • WASH and NTDs
    • Health systems factors
    • Skin-NTDs
    • Preventive Chemotherapy
    • Health education
  • Toolkits [5]
    • Guides on Stigma and Mental Wellbeing [5]
      • Guide 1. What are health-related stigma and mental wellbeing? [8]
        • 1. What is stigma?
        • 2. Why does stigma exist?
        • 3. What are the causes of stigma?
        • 4. Who stigmatises?
        • 5. How does it feel to experience stigma?
        • 6. What are the effects of stigma?
        • 7. Effects of stigma and discrimination on mental wellbeing
        • Annex Guide 1
      • Guide 2. How to reduce the impact of stigma [7]
        • 1. From undetected disease to diagnosis to support
        • 2. Individual-level interventions
        • 3. Group-level interventions
        • 4. Family-level interventions
        • 5. Referral
        • 6. Further reading
        • Annexes Guide 2
      • Guide 3. How to reduce sources of stigma [6]
        • 1. Background to the design of a stigma-reduction intervention
        • 2. Identifying the sources of stigma
        • 3. Targeting an intervention
        • 4. Inclusion of affected persons and champions in interventions
        • 5. Interventions by source type
        • Annexes Guide 3
      • Guide 4. How to assess health-related stigma and mental wellbeing [9]
        • 1. What is the purpose of the assessment?
        • 2. What approach would best fit your purpose and context?
        • 3. Quantitative assessment methods
        • 4. Qualitative assessment methods
        • 5. Assessments using mixed methods
        • 6. Developing qualitative methods from scratch
        • 7. How do you conduct a stigma assessment?
        • 8. How to interpret and report your findings
        • Annexes Guide 4
      • Glossary
    • Perception Study Toolkit (PST)
    • NTD Morbidity and Disability Measurement Toolkit [15]
      • CHIEF
      • Clinical Profile
      • EMIC affected persons
      • EMIC-CS Community Stigma
      • Participation Scale
      • Patient Health Questionnaire (PHQ-9)
      • 5-Question Stigma Indicators
      • Salsa Scale
      • SARI Stigma Scale
      • SDS Social Distance Scale
      • SRQ Self-reporting Questionnaire
      • Warwick-Edinburgh Mental Wellbeing Scale (WEMWBS)
      • WGQ Washington Group Questions
      • WHODAS
      • WHOQOL-BREF
    • NTD Toolbox
    • CBM's Community Mental Health Good Practice Guides
  • Online courses

Top menu infoNTD

  • About InfoNTD
  • News & Events
  • e-learning.infoNTD.org
Visit our e-learning platform
Search resources Search in Practical Materials, Publications, Organizations, Online Course and more
Publication

The photodynamic effects of protoporphyrin IX, protoporphyrin IX dimethyl ester or metallated protoporphyrin IX on Leishmania tarentolae in culture

Victoria H. Nguyen , Kristin D. Droege , Matthew L. Beio , et al. Trends in Photochemistry and Photobiology. 2012;
Download PDF
Publication

Application of CRISPR-Cas9 Technology in Visceral Leishmaniasis Research: Current Understanding and Future Perspective

Suprativ Das , Abul Hasan Sardar . International Journal on Science and Technology (IJSAT). 2026; 17 (1) : 1-23.
Download PDF
Publication

Formulation and evaluation of amphotericin B emulsion gel against Leishmania major in a murine model: parasite burden, gene expression, and histopathological profiling.

Safavi N, Ohadi M, Dehghannoudeh G, et al. Parasitology research. 2026; 125 (1) : 1-13.
Download PDF
Publication

Leishmaniasis: a story of two continents.

Balakrishnan V. The Lancet. Infectious diseases. 2026;
Publication

The genome of Phlebotomus chinensis, the primary vector of visceral leishmaniasis in China: insights from chromosome-level assembly and comparative analysis.

Dong H, Shan W, Zhou Q, et al. Infectious diseases of poverty. 2026; 15 (1) : 1-16.
Download PDF
Publication

Defining onchocerciasis transmission zones: Integrating operational insights with genomic and ecological advances

Elaagip A, Lassane K, de Souza DK, et al. Oxford University Press (OUP). International Health. 2026;
Download PDF
Practical material

Strengthening medicine procurement and supply chain management for neglected tropical diseases in 2025: achievements, challenges and way forward

WHO/Department of control of neglected tropical diseases . 2026;
Access resource
Publication

Incorporating lived experience of neglected tropical diseases strengthens health research

Fastenau A, Onyima-Esmai AS, Kpeh B, et al. Springer Science and Business Media LLC. Nature Health. 2026;
Download PDF
Practical material

Webinar: Skin-NTDs Across Borders: The Impact of Migration and Climate Change on Skin Health

International League of Dermatological Societies. 2026;
Access resource
Practical material

Delivering health interventions to special populations: Trachoma Toolkit Webinar

iCHORDS . 2026;
Access resource

Pagination

  • Previous page ‹‹
  • Page 2
  • Next page ››
Subscribe to Neglected tropical diseases (NTDs)

Quick Links

  • Toolbox
  • Publications
  • Organizations
  • NTDs

Support

  • Contact
  • FAQ
  • Privacy statement

Contact us infoNTD

info@InfoNTD.org

(+31) 20 595 0526

     

Stay up to date with the latest developments in NTDs. We share a monthly overview via email showing a selection of the latest NTD publications and tools. 

Subscribe

Related websites:

© 2026 InfoNTD